Aristopharma to make medicines for Sq.

Main native drugmaker Aristopharma has signed a contract manufacturing take care of market chief Sq. Prescribed drugs PLC to provide some merchandise for the latter.

Aristopharma will manufacture some injectable objects, tablets and dry syrups for the listed prescription drugs firm, officers of the 2 corporations instructed The My Information.

The board of administrators of Sq. Prescribed drugs gave go-ahead to the contract manufacturing settlement on July 12 this yr to satisfy elevated demand of its present merchandise and to introduce new merchandise.

Sq. Prescribed drugs shared the data by a posting on the web site of the Dhaka Inventory Change (DSE) yesterday.

Aristopharma is a non-listed firm that began its operations in 1986 and has a state-of-the-art manufacturing plant in Dhaka’s Shampur-Kadamtali.

Yesterday, inventory costs of Sq. Prescribed drugs remained nearly the identical as yesterday and traded at Tk 209 on the DSE.

Throughout July of 2022 to March of 2023, Sq.’s gross sales grew 10 per cent year-on-year to Tk 4,814 crore.

Star Enterprise Report

Fri Aug 4, 2023 12:00 AM Final replace on: Fri Aug 4, 2023 01:50 AM

Main native drugmaker Aristopharma has signed a contract manufacturing take care of market chief Sq. Prescribed drugs PLC to supply some merchandise for the latter.

Aristopharma will manufacture some injectable objects, tablets and dry syrups for the listed prescription drugs firm, officers of the 2 companies instructed The My Information.

For all latest news, follow The My News’s Google News channel.

The board of administrators of Sq. Prescribed drugs gave go-ahead to the contract manufacturing settlement on July 12 this yr to fulfill elevated demand of its current merchandise and to introduce new merchandise.

Sq. Prescribed drugs shared the data via a posting on the web site of the Dhaka Inventory Alternate (DSE) yesterday.

Aristopharma is a non-listed firm that began its operations in 1986 and has a state-of-the-art manufacturing plant in Dhaka’s Shampur-Kadamtali.

Yesterday, inventory costs of Sq. Prescribed drugs remained nearly the identical as the day gone by and traded at Tk 209 on the DSE.

Throughout July of 2022 to March of 2023, Sq.’s gross sales grew 10 per cent year-on-year to Tk 4,814 crore.

Star Enterprise Report

Fri Aug 4, 2023 12:00 AM Final replace on: Fri Aug 4, 2023 01:50 AM

Main native drugmaker Aristopharma has signed a contract manufacturing take care of market chief Sq. Prescribed drugs PLC to supply some merchandise for the latter.

Aristopharma will manufacture some injectable gadgets, tablets and dry syrups for the listed prescription drugs firm, officers of the 2 corporations instructed The My Information.

For all latest news, follow The My News’s Google News channel.

The board of administrators of Sq. Prescribed drugs gave go-ahead to the contract manufacturing settlement on July 12 this 12 months to fulfill elevated demand of its current merchandise and to introduce new merchandise.

Sq. Prescribed drugs shared the data by a posting on the web site of the Dhaka Inventory Change (DSE) yesterday.

Aristopharma is a non-listed firm that began its operations in 1986 and has a state-of-the-art manufacturing plant in Dhaka’s Shampur-Kadamtali.

Yesterday, inventory costs of Sq. Prescribed drugs remained nearly the identical as the day prior to this and traded at Tk 209 on the DSE.

Throughout July of 2022 to March of 2023, Sq.’s gross sales grew 10 per cent year-on-year to Tk 4,814 crore.